Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Bevacizumab in Elderly NSCLC
NCT02179567Phase 2Terminated
- Sponsor
- Hellenic Oncology Research Group
- Start
- Mar 2010
- Primary completion
- Mar 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in non-small cell lung cancer (NSCLC), sponsored by Hellenic Oncology Research Group. Started Mar 2010; status: terminated.
02
Drugs
bevacizumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02179567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02179567.